Related Experiment Video
Updated: Jan 24, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
Published on: December 30, 2025
Adipose tissue macrophage-derived exosomal miR-29a regulates obesity-associated insulin resistance
Ting Liu1, Yu-Chen Sun1, Peng Cheng2
1Department of Endocrinology, Changsha Central Hospital, Changsha, Hunan, 410004, China.
Abstract:
Obesity-associated insulin resistance is a forerunner of type 2 diabetes. Macrophages reside within adipose tissue (ATMs) have been reported to regulate insulin sensitivity through secreting miRNAs containing exosomes. Here, we show that miR-29a is increased in obese ATMs derived exosomes (ATMs-Exos) and can be transferred into adipocytes, myocytes and hepatocytes causing insulin resistance in vitro and in vivo. Administration of obese ATMs-Exos impairs insulin sensitivity of lean mice. While knockdown miR-29a level in obese ATM-Exos blunts this effect. PPAR-δ is identified to function as downstream target of miR-29a in regulating insulin resistance. PPAR-δ agonist GW501516 partially rescued the insulin resistance induced by miR-29a. Taken together, these findings suggest that ATMs derived exosomal miR-29a could regulate obesity-associated insulin resistance, which may serve as a potential therapeutic target for obesity-associated type 2 diabetes.
Insights
Obesity increases exosomal miR-29a from adipose tissue macrophages, impairing insulin sensitivity. Targeting this microRNA offers a potential therapy for obesity-associated type 2 diabetes.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Molecular Biology
Background:
- Obesity-associated insulin resistance precedes type 2 diabetes.
- Macrophages in adipose tissue regulate insulin sensitivity via exosome-secreted miRNAs.
Purpose of the Study:
- To investigate the role of exosomal miR-29a derived from obese adipose tissue macrophages (ATMs) in insulin resistance.
- To identify the mechanism by which miR-29a contributes to insulin resistance.
Main Methods:
- Quantification of miR-29a in exosomes from obese ATMs.
- In vitro and in vivo transfer of exosomal miR-29a into target cells.
- Administration of obese ATMs-Exos to lean mice.
- Knockdown of miR-29a in obese ATM-Exos.
- Identification of PPAR-δ as a downstream target.
- Assessment of insulin sensitivity and effects of PPAR-δ agonist.
Main Results:
- miR-29a levels are elevated in exosomes derived from obese ATMs.
- Obese ATMs-Exos transfer miR-29a into adipocytes, myocytes, and hepatocytes, inducing insulin resistance.
- Administration of obese ATMs-Exos impairs insulin sensitivity in lean mice.
- Knockdown of miR-29a in obese ATM-Exos mitigates insulin resistance.
- PPAR-δ is a downstream target of miR-29a, and its agonist partially rescues insulin resistance.
Conclusions:
- Exosomal miR-29a from obese ATMs contributes to obesity-associated insulin resistance.
- miR-29a acts via the PPAR-δ pathway.
- Exosomal miR-29a represents a potential therapeutic target for obesity-related type 2 diabetes.
More Related Videos
Related Concept Videos
Obesity
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Insulin Secretory Vesicles
Master Transcription Regulators
Epigenetic Regulation
GTPases and their Regulation
Large G-proteins,...

